JGC
ALXN

J. Goldman & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

J. Goldman & Co’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,600
Closed -$563K – 335
2016
Q4 		$563K Buy
+4,600
New +$563K 0.04% 159
2013
Q4 		– Hold
0
– – – 225
2013
Q3 		– Hold
0
– – – 266